Commonwealth Medicine is pleased to welcome Kaha Hizanishvili, MBA, MALD, as the new associate executive vice chancellor, Market Growth and Transformation. He will serve on the executive leadership team, driving product development and identifying opportunities for growth.
UMass Chan Medical School has been named to The Boston Globe’s 2022 list of Top Places to Work in Massachusetts. Commonwealth Medicine is proud to be part of UMass Chan.
Commonwealth Medicine, UMass Chan Medical School, was one of the proud co-sponsors of the Massachusetts Emerging Adult Summit on Nov. 2, 2022.
Every year, between Sept. 15-Oct. 15, the United States celebrates Hispanic Heritage Month, honoring the generations of Hispanic Americans who have positively influenced and enriched our nation and society. This includes both citizens and residents of the U.S. whose ancestry is traced to Spain, Mexico, the Caribbean, and Central and South America.
The New England Newborn Screening Program, an initiative of UMass Chan Medical School’s Commonwealth Medicine division, recently received HCU Network America’s first newborn screening research grant. The award will be used to explore the development of reference ranges for additional newborn screening markers for early detection of classical homocystinuria (HCU) and remethylation disorders.
Jatin Dave, MD, MPH, chief medical officer for MassHealth and director of Commonwealth Medicine’s Office of Clinical Affairs, has been selected by the Milbank Memorial Fund for its 2022–2023 Fellows Program. The Fund is an endowed operating foundation that invests in the development of state leaders who are committed to advancing population health and health equity in their communities.
Commonwealth Medicine is pleased to welcome Alda Rego, MPA, as the new managing director of Health Care Finance Solutions, under the direction of Executive Vice Chancellor Lisa M. Colombo, DNP, MHA, RN.
Commonwealth Medicine hosted the Annual Paving the Way to Health Care Access Conference this June, and its virtual format didn’t deter attendees from 15 states and 60 organizations, representing 27 languages. The conference’s speakers, award presentation, and workshops attracted some 200 medical interpreters and managers as well as spoken language and American Sign Language (ASL) interpreters on both days of the event—a testament to the resilience of those gathered for one of the nation’s premier language access conferences.
The Center on Child Wellbeing and Trauma's executive director Audrey Smolkin and the Massachusetts Office of the Child Advocate Director Maria Mossaides recently talked about the center with Massachusetts State Senator Harriette Chandler on her show "Beacon Hill Chat" on WCCA TV.
During the last week of March, a group of Commonwealth Medicine pharmacy experts participated in the Academy of Managed Care Pharmacy (AMCP)'s 2022 Conference in Chicago where they shared their research and clinical expertise on a wide range of topics.
Congratulations to Thomas C. Pomfret, PharmD, MPH, BCPS, pharmacy residency program director and clinical consultant pharmacist team lead, who received the Academy of Managed Care Pharmacy (AMCP) Residency Director Award at the AMCP meeting in Chicago on Thursday, March 31.
Eliza Anderson, PharmD, and Wilson Haong, PharmD, MBA, residents in the Managed Care Pharmacy Residency Program at Commonwealth Medicine, recently received one of two American Drug Utilization Review Society’s (ADURS) 2022 Elgene “Jake” Jacobs Memorial Scholarships for their research on prescription stimulant use in a state Medicaid population.
Commonwealth Medicine at UMass Chan Medical School is pleased to announce Jorge Sanchez, MEd, has been named the inaugural program director of Diversity and Inclusion.
Commonwealth Medicine at UMass Chan Medical School is pleased to welcome Andrea Bresnahan, DNP, as the executive director of the Nursing Council on Workforce Sustainability (NCWS), part of a statewide effort to tackle the nursing shortages in Massachusetts.
Commonwealth Medicine is a recipient of one of these grants, and will use these funds to conduct research on the knowledge, attitudes, and practices of pharmacists regarding treating and preventing substance use disorder, harm reduction, and how stigma may affect services.